AstraZeneca's dynamic duo wants to dominate in cancer drugs - STAT

  1. AstraZeneca's dynamic duo wants to dominate in cancer drugs  STAT
  2. Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation  CNN
  3. ASCO: AZ, Merck's Lynparza fends off pancreatic cancer, cutting progression risk in half  FiercePharma
  4. New drug therapy slows spread of pancreatic cancer: study  St. Lucia News Online
  5. Lynparza stalls pancreatic cancer in patients with BRCA mutations: study  CNA
  6. View full coverage on Google News


from Top stories - Google News June 02, 2019 at 05:33PM

Comments

Popular posts from this blog